← All trials
NCT05146245
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2024
- First posted
- Dec 6, 2021
- Last posted
- Dec 6, 2021
- Enrollment
- 140
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Erasmus University RotterdamLead sponsor
- Erasmus University RotterdamReponsible party - principal investigator
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- Stichting de MerelCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.